A phase I, dose-escalation trial of continuous and pulsed-dose afatinib (A) combined with pemetrexed (P) in patients (pts) with advanced solid tumors: Final analysis.

被引：0
|
作者：
Chu, Quincy S.
Sangha, Randeep S.
Hotte, Sebastien J.
Sergenson, Gwen
Chand, Vikram K.
Sufan, Roxana
Gu, Yu
Schnell, David
Hirte, Hal W.
机构：
[1] Cross Canc Ctr, Edmonton, AB, Canada
[2] Juravinski Canc Ctr, Hamilton, ON, Canada
[3] Boehringer Ingelheim GmbH & Co KG, Ridgefield, CT USA
[4] Boehringer Ingelheim Canada Ltd, Burlington, ON, Canada
[5] Boehringer Ingelheim GmbH & Co KG, Biberach, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2523
引用
收藏
页数：1
相关论文
共 50 条
  • [31] PHASE IB DOSE-ESCALATION STUDY OF THE AKT INHIBITOR IPATASERTIB (IPAT) WITH PACLITAXEL (P) IN PATIENTS (PTS) WITH ADVANCED SOLID TUMORS
    Isakoff, S. J.
    Infante, J. R.
    Juric, D.
    Chan, W. Y.
    Jia, S.
    Musib, L.
    Zhu, J.
    Meng, R.
    Patel, P. H.
    Bendell, J. C.
    ANNALS OF ONCOLOGY, 2014, 25
  • [32] Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients with Advanced Solid Tumors
    Yamada, Kazuhiko
    Yamamoto, Noboru
    Yamada, Yasuhide
    Nokihara, Hiroshi
    Fujiwara, Yutaka
    Hirata, Taizo
    Koizumi, Fumiaki
    Nishio, Kazuto
    Koyama, Noriyuki
    Tamura, Tomohide
    CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2528 - 2537
  • [33] A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours
    Diaz-Padilla, I.
    Siu, L. L.
    San Pedro-Salcedo, M.
    Razak, A. R. A.
    Colevas, A. D.
    Shepherd, F. A.
    Leighl, N. B.
    Neal, J. W.
    Thibault, A.
    Liu, L.
    Lisano, J.
    Gao, B.
    Lawson, E. B.
    Wakelee, H. A.
    BRITISH JOURNAL OF CANCER, 2012, 107 (04) : 604 - 611
  • [34] A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours
    I Diaz-Padilla
    L L Siu
    M San Pedro-Salcedo
    A R A Razak
    A D Colevas
    F A Shepherd
    N B Leighl
    J W Neal
    A Thibault
    L Liu
    J Lisano
    B Gao
    E B Lawson
    H A Wakelee
    British Journal of Cancer, 2012, 107 : 604 - 611
  • [35] Phase I trial of fruquintinib in patients with advanced solid tumors; Results of the dose escalation phase
    Wang-Gillam, A.
    Yeckes-Rodin, H.
    Kosmo, M. A.
    Stanton, T.
    Park, H.
    Songhua, F.
    Sauter, N. P.
    Kania, M.
    ANNALS OF ONCOLOGY, 2019, 30 : 175 - +
  • [36] Sunitinib combined with pemetrexed and cisplatin in patients with advanced solid malignancies: phase I dose escalation study
    Blais, N.
    Camidge, D. R.
    Jonker, D. J.
    Soulieres, D.
    Doebele, R. C.
    Ruiz-Garcia, A.
    Thall, A.
    Chao, R.
    Eckhardt, S. G.
    Chow, L. Q.
    EJC SUPPLEMENTS, 2009, 7 (02): : 552 - 552
  • [37] Final results of a phase I dose-escalation study of ON 01910.Na in combination with oxaliplatin in patients with advanced solid tumors
    Ohnuma, T.
    Holland, J. F.
    Goel, S.
    Wilck, E.
    Lehrer, D.
    Ghalib, M. H.
    Chaudhary, I.
    Wilhelm, F.
    Swami, U.
    Mani, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [38] A phase I dose-escalation study of the MDM2-p53 antagonist BI 907828 in patients (pts) with advanced solid tumors.
    LoRusso, Patricia
    Gounder, Mrinal M.
    Patel, Manish R.
    Yamamoto, Noboru
    Bauer, Todd Michael
    Laurie, Scott
    Grempler, Rolf
    Davenport, Teffany
    Geng, Junxian
    Rohrbacher, Maren
    Lahmar, Mehdi
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [39] Sunitinib (SU) plus docetaxel (D) in patients (pts) with advanced solid tumors: a phase I dose-escalation and pharmacokinetic (PK) study
    Traynor, A.
    Sandler, A.
    Schiller, J. H.
    Ilagan, J.
    Harper, K.
    VerMeulen, W.
    Liu, G.
    Tye, L.
    Chao, R.
    Robert, F.
    EJC SUPPLEMENTS, 2007, 5 (04): : 110 - 110
  • [40] Phase I dose-escalation study of brostallicin in combination with cisplatin (cDDP) in patients with advanced solid tumors
    Lorusso, D.
    Fornari, G.
    Caponigro, F.
    Quirino, M.
    Merlano, M.
    Airoldi, M.
    Schena, M.
    Jannuzzo, M. G.
    Crippa, S.
    Scambia, G.
    EJC SUPPLEMENTS, 2007, 5 (04): : 111 - 112
12345